Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grotta, J. C.
Right arrow Articles by Vital, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grotta, J. C.
Right arrow Articles by Vital, D.
NEUROLOGY 1985;35:632
© 1985 American Academy of Neurology

Does platelet antiaggregant therapy lessen the severity of stroke?

James C. Grotta, MD, Noreen A. Lemak, MD, Howard Gary, PhD, William S. Fields, MD and Doralene Vital, RN

Department of Neurology (Dr. Grotta and Ms. Vital), The University of Texas Medical School, and the Section of Neurology (Drs. Lemak, Gary, and Fields), The University of Texas M.D. Anderson Hospital and Tumor Institute.

Data from the Aspirin in Transient Ischemic Attack (AITIA) study, an ongoing study of two platelet antiaggregant drugs, and other published therapeutic trials were reviewed to determine whether the severity of stroke is reduced in patients taking platelet antiaggregants. Data from three of four studies suggest that strokes in treated patients are less severe than those in untreated patients. Further studies evaluating platelet antiaggregant therapy should include assessment of the severity as well as the incidence of stroke.

Address correspondence and reprint requests to Dr. Grotta, The University of Texas Medical School at Houston, Department of Neurology, PO Box 20708, Houston, TX 77030.

The AITIA study was supported by NHLBI grant #HL-14340-03.

Accepted for publication September 27, 1984.




This article has been cited by other articles:


Home page
StrokeHome page
S. Ricci, S. Lewis, P. Sandercock, and on behalf of the IST Collaborative Group
Previous Use of Aspirin and Baseline Stroke Severity: An Analysis of 17 850 Patients in the International Stroke Trial
Stroke, July 1, 2006; 37(7): 1737 - 1740.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Sanossian, J. L. Saver, V. Rajajee, S. L. Selco, D. Kim, T. Razinia, and B. Ovbiagele
Premorbid antiplatelet use and ischemic stroke outcomes
Neurology, February 14, 2006; 66(3): 319 - 323.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Castellanos, J. Castillo, M. M. Garcia, R. Leira, J. Serena, A. Chamorro, and A. Davalos
Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target
Stroke, April 1, 2002; 33(4): 982 - 987.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. De Cristobal, A. Cardenas, I. Lizasoain, J. C. Leza, P. Fernandez-Tome, P. Lorenzo, and M. A. Moro
Inhibition of Glutamate Release via Recovery of ATP Levels Accounts for a Neuroprotective Effect of Aspirin in Rat Cortical Neurons Exposed to Oxygen-Glucose Deprivation
Stroke, January 1, 2002; 33(1): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. L. Wilterdink, B. Bendixen, H. P. Adams Jr, R. F. Woolson, W. R. Clarke, and M. D. Hansen
Effect of Prior Aspirin Use on Stroke Severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Stroke, December 1, 2001; 32(12): 2836 - 2840.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. C. Grotta, K. M. A. Welch, S. C. Fagan, M. Lu, M. R. Frankel, T. Brott, S. R. Levine, P. D. Lyden, and P. D. Lyden
Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke, March 1, 2001; 32(3): 661 - 668.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. S. Wong
Risk Factors for Early Death in Acute Ischemic Stroke and Intracerebral Hemorrhage : A Prospective Hospital-Based Study in Asia
Stroke, November 1, 1999; 30(11): 2326 - 2330.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Sivenius, L. Cunha, H.-C. Diener, C. Forbes, M. Laakso, A. Lowenthal, P. Smets, and P. Riekkinen Sr.
Antiplatelet treatment does not reduce the severity of subsequent stroke
Neurology, September 1, 1999; 53(4): 825 - 825.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. R. Mayberg, S. E. Wilson, F. Yatsu, D. G. Weiss, L. Messina, L. A. Hershey, C. Colling, J. Eskridge, D. Deykin, H. R. Winn, et al.
Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis
JAMA, December 18, 1991; 266(23): 3289 - 3294.
[Abstract] [PDF]


Home page
Vasc MedHome page
J. C Grotta
Prevention and management of stroke
Vascular Medicine, March 1, 1991; 2(1): 3 - 17.
[PDF]


Home page
Arch NeurolHome page
M. Fisher, A. M. Blumenfeld, and T. W. Smith
The Importance of Carotid Artery Plaque Disruption and Hemorrhage
Arch Neurol, October 1, 1987; 44(10): 1086 - 1089.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.